These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 11597316)

  • 21. Expression of E-cadherin, Snail and Hakai in epithelial cells isolated from the primary tumor and from peritumoral tissue of invasive ductal breast carcinomas.
    Makdissi FB; Machado LV; Oliveira AG; Benvenuti TT; Katayama ML; Brentani MM; Osório CA; Mourão Netto M; Lyra EC; Carvalho F; Góes JC; Folgueira MA
    Braz J Med Biol Res; 2009 Dec; 42(12):1128-37. PubMed ID: 19893985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Cdc42/Rac1 regulator CdGAP is a novel E-cadherin transcriptional co-repressor with Zeb2 in breast cancer.
    He Y; Northey JJ; Pelletier A; Kos Z; Meunier L; Haibe-Kains B; Mes-Masson AM; Côté JF; Siegel PM; Lamarche-Vane N
    Oncogene; 2017 Jun; 36(24):3490-3503. PubMed ID: 28135249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic silencing in non-neoplastic epithelia identifies E-cadherin (CDH1) as a target for chemoprevention of lobular neoplasia.
    Zou D; Yoon HS; Perez D; Weeks RJ; Guilford P; Humar B
    J Pathol; 2009 Jun; 218(2):265-72. PubMed ID: 19294736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insights into E-Cadherin Impairment in
    Uchida S; Sugino T
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cadherins in cancer.
    Strumane K; Berx G; Van Roy F
    Handb Exp Pharmacol; 2004; (165):69-103. PubMed ID: 20455091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mapping the chromosome 16 cadherin gene cluster to a minimal deleted region in ductal breast cancer.
    Chalmers IJ; Aubele M; Hartmann E; Braungart E; Werner M; Höfler H; Atkinson MJ
    Cancer Genet Cytogenet; 2001 Apr; 126(1):39-44. PubMed ID: 11343777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LGR6-dependent conditional inactivation of E-cadherin and p53 leads to invasive skin and mammary carcinomas in mice.
    Ter Steege EJ; Sijnesael T; Enserink L; Klarenbeek S; Haakma WE; Bakker ERM; Derksen PWB
    Neoplasia; 2023 Jan; 35():100844. PubMed ID: 36371908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aberrant expression of E-cadherin in lobular carcinomas of the breast.
    Da Silva L; Parry S; Reid L; Keith P; Waddell N; Kossai M; Clarke C; Lakhani SR; Simpson PT
    Am J Surg Pathol; 2008 May; 32(5):773-83. PubMed ID: 18379416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-resolution analysis of 16q22.1 in breast carcinoma using DNA amplifiable probes (multiplex amplifiable probe hybridization technique) and immunohistochemistry.
    Rakha EA; Armour JA; Pinder SE; Paish CE; Ellis IO
    Int J Cancer; 2005 May; 114(5):720-9. PubMed ID: 15609312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer?
    Cleton-Jansen AM
    Breast Cancer Res; 2002; 4(1):5-8. PubMed ID: 11879552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of E-cadherin, alpha-catenin, and beta-catenin in tubulolobular carcinoma of the breast.
    Kuroda H; Tamaru J; Takeuchi I; Ohnisi K; Sakamoto G; Adachi A; Kaneko K; Itoyama S
    Virchows Arch; 2006 Apr; 448(4):500-5. PubMed ID: 16538444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cadherins and catenins in breast cancer.
    Cowin P; Rowlands TM; Hatsell SJ
    Curr Opin Cell Biol; 2005 Oct; 17(5):499-508. PubMed ID: 16107313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-suppressor function of Beclin 1 in breast cancer cells requires E-cadherin.
    Wijshake T; Zou Z; Chen B; Zhong L; Xiao G; Xie Y; Doench JG; Bennett L; Levine B
    Proc Natl Acad Sci U S A; 2021 Feb; 118(5):. PubMed ID: 33495338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CDH1 mutations are present in both ductal and lobular breast cancer, but promoter allelic variants show no detectable breast cancer risk.
    Lei H; Sjöberg-Margolin S; Salahshor S; Werelius B; Jandáková E; Hemminki K; Lindblom A; Vorechovský I
    Int J Cancer; 2002 Mar; 98(2):199-204. PubMed ID: 11857408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between E-cadherin abnormal expressions in different types of cancer and the process of metastasis.
    Mărgineanu E; Cotrutz CE; Cotrutz C
    Rev Med Chir Soc Med Nat Iasi; 2008; 112(2):432-6. PubMed ID: 19295016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma.
    Rasbridge SA; Gillett CE; Sampson SA; Walsh FS; Millis RR
    J Pathol; 1993 Feb; 169(2):245-50. PubMed ID: 8383197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast.
    Droufakou S; Deshmane V; Roylance R; Hanby A; Tomlinson I; Hart IR
    Int J Cancer; 2001 May; 92(3):404-8. PubMed ID: 11291078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
    Yoshida R; Kimura N; Harada Y; Ohuchi N
    Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Ca
    Dang DK; Makena MR; Llongueras JP; Prasad H; Ko M; Bandral M; Rao R
    Mol Cancer Res; 2019 Aug; 17(8):1735-1747. PubMed ID: 31076498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of E-cadherin and its relation to the p53 protein status in human breast carcinomas.
    Bukholm IK; Nesland JM; Kåresen R; Jacobsen U; Børresen-Dale AL
    Virchows Arch; 1997 Nov; 431(5):317-21. PubMed ID: 9463572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.